000538 Stock Overview
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Yunnan Baiyao Group Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥59.97 |
| 52 Week High | CN¥67.10 |
| 52 Week Low | CN¥44.88 |
| Beta | 0.43 |
| 1 Month Change | 0.74% |
| 3 Month Change | 19.44% |
| 1 Year Change | 23.65% |
| 3 Year Change | -15.71% |
| 5 Year Change | -4.22% |
| Change since IPO | 15,274.99% |
Recent News & Updates
Calculating The Fair Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Oct 03
Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Business And Shares Still Trailing The Market
Sep 15Recent updates
Calculating The Fair Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Oct 03Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Business And Shares Still Trailing The Market
Sep 15Yunnan Baiyao GroupLtd (SZSE:000538) Could Easily Take On More Debt
Aug 06A Look At The Intrinsic Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Jun 30Earnings Working Against Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Share Price
Apr 21Yunnan Baiyao Group Co.,Ltd Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Apr 02Yunnan Baiyao Group Co.,Ltd (SZSE:000538) Shares Could Be 34% Above Their Intrinsic Value Estimate
Feb 27Shareholder Returns
| 000538 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 3.0% | -1.9% | -1.2% |
| 1Y | 23.6% | -1.8% | 11.8% |
Return vs Industry: 000538 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 000538 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 000538 volatility | |
|---|---|
| 000538 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 000538 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000538's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 8,834 | Ming Dong | www.yunnanbaiyao.com.cn |
Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines.
Yunnan Baiyao Group Co.,Ltd Fundamentals Summary
| 000538 fundamental statistics | |
|---|---|
| Market cap | CN¥107.00b |
| Earnings (TTM) | CN¥4.30b |
| Revenue (TTM) | CN¥39.34b |
24.9x
P/E Ratio2.7x
P/S RatioIs 000538 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000538 income statement (TTM) | |
|---|---|
| Revenue | CN¥39.34b |
| Cost of Revenue | CN¥28.61b |
| Gross Profit | CN¥10.72b |
| Other Expenses | CN¥6.43b |
| Earnings | CN¥4.30b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.41 |
| Gross Margin | 27.26% |
| Net Profit Margin | 10.92% |
| Debt/Equity Ratio | 1.4% |
How did 000538 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield87%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yunnan Baiyao Group Co.,Ltd is covered by 39 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sandra Sun | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| YANG QIAO | Changjiang Securities Co. LTD. |